122 related articles for article (PubMed ID: 38686788)
1. Accuracy and diagnostic performance of the Bethesda system for reporting thyroid cytopathology in a tertiary endocrine surgical referral center in Belgium.
Kinet S; Cornette H; Van Den Heede K; Brusselaers N; Van Slycke S
World J Surg; 2024 Feb; 48(2):386-392. PubMed ID: 38686788
[TBL] [Abstract][Full Text] [Related]
2. Application of the Bethesda system for reporting thyroid cytopathology for classification of thyroid nodules: A clinical and cytopathological characteristics in Bhutanese population.
Choden S; Wangmo C; Maharjan S
Diagn Cytopathol; 2021 Nov; 49(11):1179-1187. PubMed ID: 34320270
[TBL] [Abstract][Full Text] [Related]
3. [On-site fine-needle aspiration cytology of thyroid nodules. Quality assurance of the Bethesda System for Reporting Thyroid Cytopathology (2008)].
Bak M; Péter I; Nyári T; Simon P; Újlaky M; Boér A; Kásler M
Orv Hetil; 2015 Oct; 156(41):1661-6. PubMed ID: 26551169
[TBL] [Abstract][Full Text] [Related]
4. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).
Ho AS; Sarti EE; Jain KS; Wang H; Nixon IJ; Shaha AR; Shah JP; Kraus DH; Ghossein R; Fish SA; Wong RJ; Lin O; Morris LG
Thyroid; 2014 May; 24(5):832-9. PubMed ID: 24341462
[TBL] [Abstract][Full Text] [Related]
5. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.
Yaprak Bayrak B; Eruyar AT
BMC Endocr Disord; 2020 Apr; 20(1):48. PubMed ID: 32293401
[TBL] [Abstract][Full Text] [Related]
6. The Presence of Hürthle Cells Does Not Increase the Risk of Malignancy in Most Bethesda Categories in Thyroid Fine-Needle Aspirates.
Ren Y; Kyriazidis N; Faquin WC; Soylu S; Kamani D; Saade R; Torchia N; Lubitz C; Davies L; Stathatos N; Stephen AE; Randolph GW
Thyroid; 2020 Mar; 30(3):425-431. PubMed ID: 32013786
[No Abstract] [Full Text] [Related]
7. Comparison of thyroid fine needle aspiration biopsy results before and after implementation of Bethesda classification.
Ozdemir D; Bestepe N; Faki S; Kilicarslan A; Parlak O; Ersoy R; Cakir B
Cytopathology; 2017 Oct; 28(5):400-406. PubMed ID: 28727204
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative frozen section can be reduced in thyroid nodules classified as Bethesda categories V and VI.
Huang J; Luo J; Chen J; Sun Y; Zhang C; Xu K; Ye Q; Huang P
Sci Rep; 2017 Jul; 7(1):5244. PubMed ID: 28701706
[TBL] [Abstract][Full Text] [Related]
9. Correlating the Bethesda System for Reporting Thyroid Cytopathology with Histology and Extent of Surgery: A Review of 21,746 Patients from Four Endocrine Surgery Registries Across Two Continents.
Inabnet WB; Palazzo F; Sosa JA; Kriger J; Aspinall S; Barczynski M; Doherty G; Iacobone M; Nordenstrom E; Scott-Coombes D; Wallin G; Williams L; Bray R; Bergenfelz A
World J Surg; 2020 Feb; 44(2):426-435. PubMed ID: 31690953
[TBL] [Abstract][Full Text] [Related]
10. Risk of Malignancy and Risk of Neoplasia in the Bethesda Indeterminate Categories: Study on 4,532 Thyroid Fine-Needle Aspirations from a Single Institution in India.
Mahajan S; Srinivasan R; Rajwanshi A; Radotra B; Panda N; Dey P; Gupta N; Nijhawan R
Acta Cytol; 2017; 61(2):103-110. PubMed ID: 28407624
[TBL] [Abstract][Full Text] [Related]
11. Impact of Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features on Revised Bethesda System Malignancy Rates at a Single Institution.
Linhares SM; Whitfield BW; Lee AF; Gordillo D; Picado O; Jeraq M; Farrá JC; Lew JI
J Surg Res; 2020 Nov; 255():152-157. PubMed ID: 32563006
[TBL] [Abstract][Full Text] [Related]
12. Effect of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Malignancy Rates in Thyroid Nodules: How to Counsel Patients on Extent of Surgery.
Lindeman BM; Nehs MA; Angell TE; Alexander EK; Gawande AA; Moore FD; Doherty GM; Cho NL
Ann Surg Oncol; 2019 Jan; 26(1):93-97. PubMed ID: 30341576
[TBL] [Abstract][Full Text] [Related]
13. Does a higher American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) score forecast an increased risk of malignancy? A correlation study of ACR TI-RADS with FNA cytology in the evaluation of thyroid nodules.
Modi L; Sun W; Shafizadeh N; Negron R; Yee-Chang M; Zhou F; Simsir A; Sheth S; Brandler TC
Cancer Cytopathol; 2020 Jul; 128(7):470-481. PubMed ID: 32078249
[TBL] [Abstract][Full Text] [Related]
14. The prevalence and surgical outcomes of Hürthle cell lesions in FNAs of the thyroid: A multi-institutional study in 6 Asian countries.
Agarwal S; Bychkov A; Jung CK; Hirokawa M; Lai CR; Hong S; Kwon HJ; Rangdaeng S; Liu Z; Su P; Kakudo K; Jain D
Cancer Cytopathol; 2019 Mar; 127(3):181-191. PubMed ID: 30668897
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of fine needle aspiration cytology in pediatric thyroid nodules based on Bethesda Classification.
Jiang W; Phillips SA; Newbury RO; Naheedy JH; Newfield RS
J Pediatr Endocrinol Metab; 2021 Apr; 34(4):449-455. PubMed ID: 33629571
[TBL] [Abstract][Full Text] [Related]
16. Thyroid nodules with Hürthle cells: the malignancy risk in relation to the FNA outcome category.
Słowińska-Klencka D; Wysocka-Konieczna K; Woźniak-Oseła E; Sporny S; Popowicz B; Sopiński J; Kaczka K; Kuzdak K; Pomorski L; Klencki M
J Endocrinol Invest; 2019 Nov; 42(11):1319-1327. PubMed ID: 31077094
[TBL] [Abstract][Full Text] [Related]
17. Did Introducing a New Category of Thyroid Tumors (Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features) Decrease the Risk of Malignancy for the Diagnostic Categories in the Bethesda System for Reporting Thyroid Cytopathology?
Kopczyński J; Suligowska A; Niemyska K; Pałyga I; Walczyk A; Gąsior-Perczak D; Kowalik A; Hińcza K; Mężyk R; Góźdź S; Kowalska A
Endocr Pathol; 2020 Jun; 31(2):143-149. PubMed ID: 32236858
[TBL] [Abstract][Full Text] [Related]
18. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
[TBL] [Abstract][Full Text] [Related]
19. Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.
Steward DL; Carty SE; Sippel RS; Yang SP; Sosa JA; Sipos JA; Figge JJ; Mandel S; Haugen BR; Burman KD; Baloch ZW; Lloyd RV; Seethala RR; Gooding WE; Chiosea SI; Gomes-Lima C; Ferris RL; Folek JM; Khawaja RA; Kundra P; Loh KS; Marshall CB; Mayson S; McCoy KL; Nga ME; Ngiam KY; Nikiforova MN; Poehls JL; Ringel MD; Yang H; Yip L; Nikiforov YE
JAMA Oncol; 2019 Feb; 5(2):204-212. PubMed ID: 30419129
[TBL] [Abstract][Full Text] [Related]
20. Molecular Testing Has Limited Utility in the Surgical Evaluation of Bethesda III Thyroid Nodules.
Scola WH; Linhares SM; Handelsman RS; Picado O; Khan ZF; Farrá JC; Lew JI
J Surg Res; 2021 Dec; 268():209-213. PubMed ID: 34358733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
